-transparent.png){kind=logo}
The rise in plasma cyclic AMP after glucagon has been studied in hyper- and hypothyroid patients before and after treatment. In the hyperthyroid group, each individual patient showed a decrease in cyclic AMP response to glucagon on becoming euthyroid, but there was no change after treatment with propranolol. In the hypothyroid group, each individual patient showed an increase in response on becoming euthyroid on thyroxine. We suggest that peak plasma cyclic AMP response to glucagon could be used to monitor tissue responisveness to thyroid hormone during treatment of hypo- and hyperthyroidism, though change in this response is a more sensitive indicator of change from the hypothyroid to the euthyroid state than from the hyperthyroid to the euthyroid state.
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
September 1974,
Clinical science and molecular medicine,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
August 1977,
Acta endocrinologica,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
February 1977,
Diabetes,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
January 1977,
British medical journal,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
February 1991,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
August 1984,
Journal of clinical gastroenterology,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
March 1991,
Acta paediatrica Scandinavica,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
May 1985,
[Hokkaido igaku zasshi] The Hokkaido journal of medical science,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
January 1981,
International pharmacopsychiatry,
R Paisey, and
R S Elkeles, and
J Hambley, and
P E Belchetz
January 1975,
Clinical science and molecular medicine,
